Ftse Mib
34.228,77
0,71%
DAX
18.430,05
1,42%
S&P 500
5.196,88
0,31%
NASDAQ
16.392,46
0,26%
Bitcoin
63.467,93
0,48%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enanta Pharmaceuticals Inc (ENTA) Enanta Pharmaceuticals Inc (ENTA) Notizie

Enanta Pharmaceuticals Inc

ENTA
12,66
-1,94 (-13,29%)
Ultimo aggiornamento: 19:24:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202413:00BWEnanta Pharmaceuticals to Participate at the JMP Securities..
06/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
30/4/202413:10BWEnanta Pharmaceuticals Announces Inducement Grants Under..
30/4/202413:00BWEnanta Pharmaceuticals Announces the Appointment of Matthew..
29/4/202413:00BWEnanta Pharmaceuticals to Host Conference Call on May 6 at..
17/4/202413:00BWEnanta Pharmaceuticals Announces Data Presentation at ESCMID..
08/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:00BWEnanta Pharmaceuticals to Participate at Leerink Partners..
28/2/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202419:11EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
15/2/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202422:05EDGAR2Form 8-K - Current report
07/2/202422:01BWEnanta Pharmaceuticals Reports Financial Results for its..
06/2/202413:00BWEnanta Pharmaceuticals to Participate at the Oppenheimer..
31/1/202413:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
26/1/202422:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202422:25EDGAR2Form DEF 14A - Other definitive proxy statements
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202413:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
03/1/202413:00BWEnanta Pharmaceuticals to Present at the 42nd Annual J.P...
26/12/202322:06EDGAR2Form 8-K - Current report
16/12/202302:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202323:16EDGAR2Form 144 - Report of proposed sale of securities
07/12/202302:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202303:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 11,60 Min: 11,60 Max: 13,04
Chiusura: 14,60

La tua Cronologia

NASDAQ
ENTA
Enanta Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network